1. Discuss recent advances in the treatment of acute lymphoblastic leukemia;

2. Discuss recent developments in risk stratification in acute lymphoblastic leukemia

3. Explain the definitions of MGUS and smoldering myeloma

                4. Differentiate between the treatment of transplant eligible and transplant ineligible MM patients

Session date: 
02/26/2020 - 8:00am to 9:00am CST
Room G5/119 CSC
600 Highland Avenue
Madison, WI 53792
United States
  • 1.00 ACPE Contact Hours - Pharmacist
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours

Please login or register to take this course.
Discloser List CME Internal Report
Dr. Ryan Mattison
Dr. Natalie Callander